Anticoagulants and Primary PCI - Primary Angioplasty - NCBI Bookshelf
QUALITY CONTROL ANALYSIS OF TOTAL HEPARIN DOSE NEEDED FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) CORONARY INTERVENTIONS | Journal of the American College of Cardiology
Heparin Anticoagulation in Acute Coronary Syndrome — Maimonides Emergency Medicine Residency
369. Plavix mechanism and indication in ACS / Heparin mechanism and indication in ACS – emupdates
New anticoagulant strategies in ST-elevation myocardial infarction treated with fibrinolytic therapy - The British Journal of Cardiology
Anticoagulation in the cardiac patient: A concise review - Larson - 2019 - European Journal of Haematology - Wiley Online Library
Excess Heparin Dosing Among Fibrinolytic-treated Patients with ST-Segment Elevation Myocardial Infarction
Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital | BMC Cardiovascular Disorders | Full Text
Gregg W. Stone MD on Twitter: "1/ BRIGHT-4 tweetorial. 6 large RCTs have compared bivalirudin vs heparin during primary PCI in STEMI w/varying results (slide). The 2 best regimens (bival with a
Acute Coronary Syndrome (ACS) Patients | Lovenox® U.S. HCP Site
Conversations in Cardiology – Heparin Potency: What is the Right Heparin Dose for PCI in 2021?
TNKase® Dosing Guidelines
Excess Unfractionated Heparin Dosing for STEMI and NSTEMI
Evidence Review Anticoagulation in ACS & PCI - ppt download
Heparin, enoxaparin & fondaparinux in ACS — NERDCAT
Lovenox in NSTEMI — NUEM Blog
Excess Unfractionated Heparin Dosing for STEMI and NSTEMI
Acute Coronary Syndrome (ACS) - ppt download
Table 5 from Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings | Semantic Scholar
Excess Unfractionated Heparin Dosing for STEMI and NSTEMI
Heparin Anticoagulation in Acute Coronary Syndrome — Maimonides Emergency Medicine Residency
PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar